Page 1 of Clinical Trials for "Hyperlipoproteinemia Type II", 64 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Last Updated: January 17, 2012
Condition(s): Lipid Metabolism, Inborn Errors; Hypercholesterolemia, Autosomal Dominant; Hyperlipidemias; Metabolic Diseases; Hyperlipoproteinemia Type II; Metabolism, Inborn Errors; Genetic Diseases, Inborn; Infant, Newborn, Diseases; Metabolic Disorder; Congenital Abnormalities; Hypercholesterolemia; Hyperlipoproteinemias; Dyslipidemias; Lipid Metabolism Disorders
2
Completed
Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia
Last Updated: October 2, 2010
Condition(s): Lipid Metabolism, Inborn Errors; Hypercholesterolemia, Autosomal Dominant; Hyperlipidemias; Metabolic Diseases; Hyperlipoproteinemia Type II; Metabolism, Inborn Errors; Genetic Diseases, Inborn; Infant, Newborn, Diseases; Metabolic Disorder; Congenital Abnormalities; Hypercholesterolemia; Hyperlipoproteinemias; Dyslipidemias; Lipid Metabolism Disorders
3
Recruiting
Study to Assess the Tolerability and Efficacy of Anacetrapib Co-administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020 AM1)
Last Updated: May 15, 2012
Condition(s): Hyperlipoproteinemia Type II; Heterozygous Familial Hypercholesterolemia
4
Completed
Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
Last Updated: January 18, 2012
Condition(s): Lipid Metabolism, Inborn Errors; Hypercholesterolemia, Autosomal Dominant; Hyperlipidemias; Metabolic Diseases; Hyperlipoproteinemia Type II; Metabolism, Inborn Errors; Genetic Diseases, Inborn; Infant, Newborn, Diseases; Metabolic Disorder; Congenital Abnormalities; Hypercholesterolemia; Hyperlipoproteinemias; Dyslipidemias; Lipid Metabolism Disorders
5
Completed
Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578AM3)(COMPLETED)
Last Updated: June 19, 2008
Condition(s): Atherosclerosis; Hypercholesterolemia; Hyperlipoproteinemia Type II
6
Completed
Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients
Last Updated: November 30, 2010
Condition(s): Hypertriglyceridemia; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemia Type IIb; Hyperlipidemia
7
Completed
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
Last Updated: December 19, 2011
Condition(s): Myalgia; Hypercholesterolemia; Hyperlipidemia
8
Completed
Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)(COMPLETED)
Last Updated: March 17, 2010
Condition(s): Hypercholesterolemia
9
Completed
48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
Last Updated: May 27, 2009
Condition(s): Dyslipidaemia
10
Active, not recruiting
Cardiovascular Evaluation of Patients With High Cholesterol and Normal Volunteers
Last Updated: April 7, 2012
Condition(s): Atherosclerosis; Hypercholesterolemia
11
Recruiting
Atorvastatin Three Year Pediatric Study
Last Updated: April 25, 2012
Condition(s): Familial Hypercholesterolemia
12
Active, not recruiting
Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
Last Updated: March 16, 2012
Condition(s): Familial Hypercholesterolemia
13
Completed
Safety, Tolerability and Efficacy of Microsomal Triglyceride Protein (MTP) Inhibitor
Last Updated: March 16, 2012
Condition(s): Homozygous Familial Hypercholesterolemia
14
Completed
Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia
Last Updated: August 28, 2008
Condition(s): Hypercholesterolemia, Familial
15
Completed
Study of ISIS 301012 (Mipomersen) in Heterozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy
Last Updated: October 2, 2010
Condition(s): Hypercholesterolemia, Familial
16
Withdrawn
Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients
Last Updated: November 4, 2008
Condition(s): Familial Hypercholesterolemia
17
Completed
Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia
Last Updated: June 23, 2005
Condition(s): Familial Hypercholesterolemia
18
Completed
Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia
Last Updated: May 28, 2008
Condition(s): Type II Hyperlipidaemia
19
Completed
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder
Last Updated: November 5, 2007
Condition(s): Hypercholesterolemia, Familial
20
Completed
A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)(COMPLETED)
Last Updated: April 15, 2010
Condition(s): Hypercholesterolemia; Familial Hypercholesterolemia; Homozygous Sitosterolemia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?cond=%22Hyperlipoproteinemia+Type+II%22

Page 1 of Clinical Trials for "Hyperlipoproteinemia Type II", 64 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About